Antibodies against a 23Kd heparin binding fragment of thrombospondin inhibit platelet aggregation.
Antiserum against a 23Kd heparin binding fragment of thrombospondin inhibits the aggregation of platelets in response to ADP, collagen or thrombin. The antiserum inhibits the secretion-dependent second phase, but not the primary phase of aggregation of platelets responding to ADP. Although immune serum added during the second phase of ADP-induced aggregation causes some inhibition of secretion, it also causes reversal of aggregation to the level produced during primary aggregation. Since thrombospondin is the endogenous lectin of human platelets, these results support the conclusion that the endogenous lectin mediates, at least in part, the secretion-dependent aggregation of platelets. Our data suggest that the region of thrombospondin which contains the heparin binding domain(s) present in the 23Kd fragment play(s) a critical role in secretion-dependent aggregation of platelets.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D000906:Antibodies; D000936:Antigen-Antibody Complex; D002417:Cattle; D006023:Glycoproteins / Q000502:physiology*; D006493:Heparin / Q000097:blood*; D007700:Kinetics; D008970:Molecular Weight; D010446:Peptide Fragments / Q000502:physiology*; D010974:Platelet Aggregation / Q000187:drug effects; D019699:Thrombospondins
D000906:Antibodies; D000936:Antigen-Antibody Complex; D006023:Glycoproteins; D010446:Peptide Fragments; D019699:Thrombospondins; D000244:Adenosine Diphosphate; D006493:Heparin